Intramedullary Nail Market Size, Trends and Forecast to 2030

The Intramedullary Nail Market size is expected to reach USD 3.46 billion by 2030, from USD 1.95 billion in 2023, at a CAGR of 8.5% during the forecast period. Intramedullary nails are metal rods inserted into the medullary canal of long bones to stabilize fractures. They provide stability and alignment for fractures and allow early mobility. The market is driven by the rising incidence of musculoskeletal conditions requiring fixation surgeries. The Intramedullary Nail Market is segmented by product type, indication, end user, and region. By product type, the trochanteric nails segment held the largest share in 2022 owing to the high use of these nails for hip fracture fixation.

Intramedullary Nail Market Regional Insights

North America is expected to be the largest market for Intramedullary Nail Market during the forecast period, accounting for over 40.5% of the market share in 2022. The growth of the market in North America is attributed to the rising geriatric population and subsequent increase in fracture incidence.
The Europe Market is expected to be the second-largest market for Intramedullary Nail Market, accounting for over 28.7% of the market share in 2022. The growth of the market in Europe is attributed to the presence of key players and supportive reimbursement policies.
The Asia Pacific Market is expected to be the fastest-growing market for Intramedullary Nail Market, with a CAGR of over 9.1% during the forecast period. The growth of the market in Asia Pacific is attributed to the increasing healthcare expenditure and awareness.

Figure 1. Global Intramedullary Nail Market Share (%), By Region, 2023

Intramedullary Nail Market Drivers:

Increasing Incidence of Musculoskeletal Conditions: The rising incidence of musculoskeletal conditions like osteoporosis, osteoarthritis, and fractures is driving the demand for IM nails. According to the WHO, around 15% of the world's population lives with a musculoskeletal condition.
Technological Advancements in Intramedullary Nails: Key players are focusing on developing advanced IM nails made of improved materials and designs to improve fracture fixation. Some latest innovations include fenestrated nails, helical blades, and minimally invasive techniques.
Favorable Reimbursement Policies: The availability of reimbursement for IM nail surgery under Medicare, Medicaid, and other private insurance is facilitating the adoption of this procedure. This supports the cost of surgery for patients.
Rising Number of Sports Injuries: The increasing participation in sports activities globally has led to a high number of associated traumatic injuries. IM nails are extensively used to treat closed fractures resulting from sports injuries.

Intramedullary Nail Market Opportunities:

Development of Biodegradable Intramedullary Nails: Biodegradable IM nails eliminate the need for removal surgery, reducing patient trauma and healthcare costs. Companies are investing in developing nails using biodegradable materials like magnesium alloys.
Rising Demand for Minimally Invasive Surgeries: The preference for minimally invasive IM nail fixation using smaller incisions is increasing among patients. Key players are focusing on advancing minimally invasive intramedullary nailing techniques.
Growing Adoption in Emerging Markets: Developing regions like APAC and Latin America present significant opportunities, owing to improving healthcare infrastructure, rising disposable income, and increasing awareness.
Development of Customized Intramedullary Nails: Customized IM nails designed based on the patient's anatomy using 3D printing technology ensure better outcomes. Companies are increasingly investing in 3D printed customized implants.

Intramedullary Nail Market Report Coverage

Report Coverage	Details
Base Year:	2022	Market Size in 2023:	US$ 1.95 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	8.5%	2030 Value Projection:	US$ 3.46 Bn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
Segments covered:	By Product Type: Trochanteric Nails, Piriformis Entry Nails, Long Gamma Nails, Short Gamma Nails, Humeral Nails, Tibial Nails, Others By Indication: Femoral Fractures, Tibial Fractures, Humerus Fractures, Ankle Fractures, Others By End User: Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, Others By Material Type: Titanium, Stainless Steel, Others
Companies covered:	Zimmer Biomet, Smith & Nephew, Stryker, DePuy Synthes, Orthofix, Bioventus LLC, DJO Global, Braun, Medtronic, Globus Medical
Growth Drivers:	Increasing Incidence of Musculoskeletal Conditions Technological Advancements in Intramedullary Nails Favorable Reimbursement Policies Rising Number of Sports Injuries
Restraints & Challenges:	High Cost of Computer-Assisted Orthopedic Surgeries Risk of Infection in Intramedullary Nailing Procedures Lack of Reimbursement in Emerging Markets

Intramedullary Nail Market Trends:

Increasing Adoption of Robot-Assisted Surgeries: Robotic-arm assisted implantation of IM nails enables precision nail placement and reduces surgery time and radiation exposure. The adoption of robotic surgery is rising across healthcare facilities.
Rising Popularity of Intramedullary Lengthening Nails: Intramedullary lengthening nails allow for gradual, controlled limb lengthening while avoiding external frames. Their adoption for limb deformities in children and short stature is rising.
Technological Integration for Reduced Radiation: Navigation technology integration in IM nailing procedures enables real-time fracture reduction monitoring and reduces intraoperative imaging and radiation exposure.
Emergence of Online Portals for Intramedullary Nails: Leading manufacturers are selling IM nails through online portals, enabling easy accessibility for healthcare facilities. This is especially beneficial for facilities in remote areas.

Intramedullary Nail Market Restraints:

High Cost of Computer-Assisted Orthopedic Surgeries: While computer-assisted surgeries using intramedullary nails improve precision, they require high initial investments in advanced navigation systems. This can restrain adoption among low-budget healthcare facilities.
Risk of Infection in Intramedullary Nailing Procedures: Intramedullary nailing carries risks like bone infection, septic arthritis, and osteomyelitis. Concerns regarding these postoperative complications are restraining the growth of the market.
Lack of Reimbursement in Emerging Markets: The lack of insurance coverage and reimbursement for fracture fixation surgeries in developing regions limits the adoption of intramedullary nails. Patients in these countries often cannot afford the procedure cost.

Recent Developments

New product launches

In November 2022, WishBone Medical launched IM nail systems for pediatric patients including the WishBone 3.5mm Pediatric Cannulated IM Nail System.
In June 2022, Orthofix Medical launched the FITBONE intramedullary lengthening system which allows gradual limb lengthening without external frames.
In April 2022, Extremity Medical launched the Phantom Intramedullary Suprapatellar Nail for tibia fracture fixation. Its suprapatellar entry point avoids knee trauma.

Acquisition and partnerships

In March 2022, WishBone Medical acquired API Orthopaedics, gaining their PinPoint Intramedullary Nail Technology for pediatric fractures.
In January 2022, Orthofix acquired Pega Medical, expanding its intramedullary nail portfolio with the ANKLE FUSION NAIL PRO.
In November 2021, Corin Group partnered with Medacta International to distribute the latter's GMK Efficiency Sphere technology for knee replacements.

Figure 2. Global Intramedullary Nail Market Share (%), By Type, 2023

Top companies in Intramedullary Nail Market

Zimmer Biomet
Smith & Nephew
Stryker
DePuy Synthes
Orthofix
Bioventus LLC
DJO Global
Braun
Medtronic
Globus Medical

*Definition: The intramedullary nail market refers to the global market for intramedullary nails, which are metal rods surgically inserted into the marrow canal of fractured long bones. Intramedullary nails, often called IM nails, provide stability and alignment to fractures to allow mobilization during the healing process. They are most commonly used to treat fractures in the femur, tibia, and humerus bones.

Frequently Asked Questions

The key factors hampering the growth of the Intramedullary Nail Market are high costs of computer-assisted orthopedic surgeries, risks of infections associated with IM nailing procedures, lack of reimbursement in emerging economies, shortage of trained professionals, patient noncompliance to post-surgical care instructions, unfavorable taxation policies, stringent approval norms in some regions, and availability of alternative fracture fixation approaches.

The major factors driving the growth of the Market are rising incidence of musculoskeletal conditions like fractures, increasing number of road accidents and trauma cases, technological advancements in IM nail designs and techniques, investments in R&D for innovations, favorable reimbursement policies in developed nations, rising geriatric population susceptible to fractures, and growing number of sports injuries globally.

The trochanteric nails segment is the leading component in the Market owing to their high demand for fixation of hip fractures.

The major players operating in the Market are Zimmer Biomet, Stryker, Smith & Nephew, DePuy Synthes, DJO Global, Orthofix, Bioventus LLC, B.Braun, Medtronic, and Globus Medical.

North America is expected to continue leading the Market over the forecast period.